Table 1.
Characteristics of randomized subjects in two fluoxetine-discontinuation studies.
Study 1 | Study 2 | |||
---|---|---|---|---|
Characteristic | Fluoxetine (N=299) | Placebo (N=96) | Fluoxetine (N=134) | Placebo (N=135) |
Age | 39.6 ± 10.2 | 40.0 ± 10.5 | 39.8 ± 11.3 | 38.5 ± 11.1 |
% Male | 34.4 | 20.8 | 50.0 | 31.7 |
Baseline mHAM-D | 20.7 ± 3.5 | 21.5 ± 3.7 | 17.7 ± 5.1 | 17.2 ± 4.5 |
mHAM-D at randomization | 2.9 ± 2.2 | 2.7 ± 2.3 | 4.8 ± 3.0 | 5.3 ± 3.5 |
Note: Age and gender data were only available for a subset of subjects in Study 2, N=82 in each group. mHAM-D data reflect the entire randomized sample.